In several species, adult metabolic phenotype is influenced by the intrauterine environment, often in a sex-linked manner. In horses, there is also a window of susceptibility to programming immediately after birth but whether adult glucose-insulin dynamics are altered by neonatal conditions remains unknown. Thus, this study investigated the effects of birth weight, sex and neonatal glucocorticoid overexposure on glucose-insulin dynamics of young adult horses. For the first 5 days after birth, term foals were treated with saline as a control or ACTH to raise cortisol levels to those of stressed neonates. At 1 and 2 years of age, insulin secretion and sensitivity were measured by exogenous glucose administration and hyperinsulinaemic-euglycamic clamp, respectively. Glucose-stimulated insulin secretion was less in males than females at both ages, although there were no sex-linked differences in glucose tolerance. Insulin sensitivity was greater in females than males at 1 but not 2 years of age. Birthweight was inversely related to the area under the glucose curve and positively correlated to insulin sensitivity at 2 but not 1 years of age. In contrast, neonatal glucocorticoid overexposure induced by ACTH treatment had no effect on whole body glucose tolerance, insulin secretion or insulin sensitivity at either age, although this treatment altered insulin receptor abundance in specific skeletal muscles of the 2 year old horses.
INTRODUCTION
In adult animals including horses, glucose tolerance and insulin sensitivity are influenced by the nutritional, metabolic and endocrine conditions existing at the time of study. [1] [2] [3] [4] There is also increasing evidence from a range of species that conditions during intrauterine development can affect glucose-insulin dynamics of the adult offspring. [5] [6] [7] Low birthweight, in particular, has been associated with glucose intolerance and insulin insensitivity in adult mice, rats, guinea pigs, pigs and sheep as well as in human populations of different ethnicity. [8] [9] [10] [11] [12] [13] [14] Indeed, inducing intrauterine growth restriction experimentally by maternal undernutrition, glucocorticoid administration, placental insufficiency or restriction of uterine blood flow causes abnormalities in glucose metabolism and insulin action in the offspring later in postnatal life. 5, 6, 15, 16 In horses, maternal undernutrition and variations in dietary composition during pregnancy affect insulin secretion and glucose dynamics of newborn and older pre-weaning foals, even when there is no change in birth weight. [17] [18] [19] Similarly, dexamethasone treatment of mares during late pregnancy alters arginine-stimulated insulin secretion in their foals 12 weeks after birth relative to controls of the same birth weight. 20 Collectively, the experimental and epidemiological studies have led to the concept that postnatal metabolic phenotype can be programmed in utero, particularly by environmental conditions suboptimal for normal fetal development.
Recent studies in horses have suggested that there is also a window of susceptibility to metabolic and endocrine programming in the early neonatal period. 15, 16 In contrast to other precocious species, the horse matures late in gestation and is born with several of its key tissues still not terminally differentiated. 16 Indeed, glucocorticoid overexposure of the foal in the days immediately after birth alters its subsequent endocrine and metabolic profile. 21, 22 For instance, there are changes in insulin secretion in response to both glucose and arginine in the foal up to 12-14 weeks after the period of glucocorticoid overexposure. 21 In addition, in 2
week old foals, pancreatic β cell sensitivity to glucose differs with sex with greater insulin secretion in females than males. 23 However, whether the differences in glucose-insulin dynamics seen with sex and neonatal glucocorticoid exposure in pre-weaning foals persist into later life remains unknown. This study, therefore, examined glucose tolerance, insulin secretion and insulin sensitivity of young adult horses with respect to sex, birth weight and neonatal glucocorticoid overexposure.
MATERIALS AND METHODS

Animals
Nineteen ponies were used in the study. They were born spontaneously at full term (approx. 330 days of gestation) and were treated intramuscularly with equine tetanus antitoxin shortly after birth (1000 IU; Tetanus Antitoxin Intervet Ltd, UK). They were housed with their mothers in individual stables for 7 days after birth and then at grazing during the day until they were weaned at 5-6 months. Thereafter, until catheterization, they were kept at grazing during the day and housed in covered yards at night with access to hay and water. Body condition score was maintained at moderate from weaning until the end of the protocol. 24, 25 Colts and fillies occupied separate paddocks and yards from 9 months of age. All animals were wormed and had their hooves trimmed regularly. They were also weighed regularly to calculate fractional growth rates (g/kg birth weight/week) up to the experiments at 1 and 2 years of age.
Experimental Procedures
All procedures were carried out under the Animal (Scientific Procedures) Act 1986 of the UK Government after ethical permission from the University of Cambridge.
Foals
Foals were injected intramuscularly with either long-acting ACTH1-24 (0.125 mg, n=9, 4 males and 5 females, Depot Synacthen, Alliance Pharmaceuticals Ltd, Wiltshire, UK) or saline (0.9% NaCl, n= 10, 4 males and 6 females) twice daily at between 08.00 and 09.00h and between 16.30h and 17.00h for 5 days after birth beginning on the first day of postnatal life. Blood samples were taken daily from the jugular vein immediately before the first daily injection from day 1 to day 6 to measure plasma cortisol concentrations. The ACTH dose was designed to increase endogenous cortisol concentrations to the levels seen in premature or ill newborn foals 26, 27 and resulted in plasma cortisol concentrations that were higher in ACTH than saline treated foals over the 5 days of treatment (Saline, 20.4 ± 1.8 ng/ml, n = 10; ACTH, 207.2 ± 49.3 ng/ml, n = 9, P=0.01). 21 Foals were assigned to either ACTH or saline treatment alternately in the order in which they were born on the basis of their sex to ensure an even sex distribution between the two treatment groups.
Adults
Surgical procedures: At 10-13 months (yearling or 1 year old group) and again between 23-34 months (2 year old group), the ACTH and saline treated ponies were fasted over night before catheterisation under general anaesthesia with positive pressure ventilation using strict aseptic procedures as described in detail previously. 28, 29 At both ages, catheters were inserted into the caudal vena cava and dorsal aorta via the circumflex artery and vein. 28 The catheters were filled with heparinised saline (100 IU heparin/ml in 0.9% w/v NaCl), exteriorized via a stab wound in the flank and housed in a bag sutured to the side of the horse. At the end of surgery, a long stay 16-gauge catheter was placed in a jugular vein (Milacath ® , Mila International Inc., Erlanger, KY, USA) and the horse was given antibiotics ( Ltd, Commond Road, Dunnington, York, UK). For the current study, samples of liver and skeletal muscles (biceps, soleus, gastrocnemius and semitendinosus) were collected into liquid nitrogen and stored at -80ºC until required for analyses. These and other tissues were also collected for teaching and other research studies.
Biochemical analyses
Metabolite and hormone concentrations:
Blood and plasma glucose concentrations were measured using an automated analyzer (Yellow Springs 2300 Stat Plus Glucose/Lactate Analyzer; YSI Ltd., Farnborough, UK).
Plasma insulin concentrations during the glucose tolerance test and the basal samples from
the hyperinsulinaemic-euglycaemic clamp were measured using a commercially available, equine specific enzyme linked immunosorbent assay (ELISA) kit (Mercodia AB, Uppsala, Sweden), validated for use with equine plasma. 30, 31 The mean intra-assay coefficient of variation was 3.4% while the inter-assay coefficient of variation was 13%. The minimum detectable level of equine insulin was 0.01µg/l. Insulin concentrations during the clamp period were measured after dilution using commercially available human and bovine ELISA kits as appropriate (Mercodia AB, Uppsala, Sweden). The clamped insulin concentrations 7 were measured in a single assay at each age. For the human and bovine insulin assays, the minimum detectable of insulin was 0.04 µg/l and 0.02 µg/l while the intra-assay coefficient of variation was 3.4% and 3.8%, respectively.
Tissue insulin receptor abundance
Protein was extracted from liver and the four skeletal muscles and the protein concentration in the supernatant was determined using a bicinchoninic acid assay (BCA kit; Pierce, Rockford, IL). Western Blotting was performed as described previously 32 
Calculations
Glucose tolerance test: Relative insulin secretion (RIS) was calculated as area under the insulin curve (AUCI) divided by area under the glucose curve (AUCG).
RIS =
AUCI (ng/l/min)
Hyperinsulinsemic-euglycaemic clamp (HEC):
As the glucose concentration is not maintained perfectly constant during the clamp, a space correction (SC) is made to account for the glucose that has been added or removed from the glucose space other than by metabolism. 33 No correction was made for urinary losses of glucose, irrespective of whether the animals urinated or not during the course of the experiments.
The SC (µmol/kg/min) was calculated from the equation: 33 Where G2 and G1 are glucose concentration at the beginning and end of each interval of sampling, T is the time interval (10 minutes The steady-state plasma insulin concentration was calculated as the average of insulin concentrations during the clamp period.
Statistical Analyses
All For all statistical tests, significance was accepted at P<0.05.
RESULTS
Biometry
Birth weight did not differ between female and male foals (P>0.05, Table 1 ). There was also no difference in the body weight of the fillies and colts at 1 and 2 years of age (P>0.05, Table   1 ). Neonatal treatment had no effect on body weight at either age (P>0.05, Table 1 ). In addition, there were no significant differences in the fractional growth rate with sex or neonatal treatment during the period of study (P>0.05, Table 1 ).
Glucose tolerance
At 1 and 2 years of age, there were no differences in the basal fasting concentrations of plasma glucose and insulin with neonatal treatment or sex of the animals (P>0.05, Table 1 ).
At both ages, the increment in plasma glucose with respect to time and the maximal increment in plasma glucose were similar in males and females and did not differ with neonatal treatment (P>0.05, Table 1 , Figure 1A) . Similarly, the AUCG was unaffected by either sex or neonatal treatment of the animals, irrespective of their age ( Figure 1B) . The increment in plasma insulin with respect to time was also unaffected by neonatal treatment (P>0.05, Figure 1C ). However, the increment in plasma insulin from basal values was greater in females than males from 60 min to 120 min after glucose administration in the yearlings and from 30 min to120 min in the 2 year olds (P<0.02, Figure 1C) . Similarly, the the maximum concentration of plasma insulin achieved during the 120 min period after glucose administration was significantly higher in females than males at both ages (P<0.04, Table 1 ). Consequently, the AUCI was significantly greater in females than males at both ages studied (P<0.02, Figure 1D ). The relative insulin secretion were significantly greater in females than males at 2 but not 1 years of age (P<0.04, Table 1 ) and was unaffected by neonatal treatment at both ages (P>0.05, Table 1 ). When the two sexes were analysed separately, there were no changes in the increments of glucose and insulin, the AUCG and AUCI or in RI between 1 and 2 years of age in either sex (P>0.05, two-way ANOVA, all cases)
Insulin sensitivity
Basal blood glucose concentrations did not vary with sex or neonatal treatment at either age (P>0.05, all cases; mean values: 1 year, 4.49 ± 0.17 mmol/l, n = 13; 2 years, 4.70 ± 0.19 mmol/l, n = 17) and were clamped at these basal euglycaemic levels by 2-5h after beginning the insulin infusion. At this time, insulin concentrations were supra-physiological and did not vary with neonatal treatment or sex of the animal at either 1 or 2 years of age (P>0.05, all cases: mean clamped values; 1 year, 52.5 ± 5.1 µg/l, n = 13, 2 years, 59.6 ± 5.6 µg/l, n =17).
At both ages, the effectiveness of insulin in stimulating tissue glucose uptake was unaffected by neonatal treatment, whether measured as GIR or insulin sensitivity (P>0.05, Figure 2 ).
Females had a greater GIR and insulin sensitivity than males as yearlings but not as 2 years olds ( Figure 2 ). When the data from the two treatment groups were combined and analysed by two-way ANOVA with respect to age and sex of the animals, there was an interaction between these two factors in determining insulin sensitivity with a decline in insulin sensitivity with increasing age in females (P<0.001, n = 9) but not in males (P>0.05, n = 8).
Insulin receptor abundance in the liver and selected skeletal muscles was unaffected by sex in a subset of the animals at 2 years of age (P>0.05, two-way ANOVA, all cases, Figure 3 ).
However, skeletal muscle InsR abundance was influenced by neonatal treatment in a muscle specific manner with increased abundance in the soleus and gastrocnemius muscles and decreased abundance in the semitendinosus muscle of animals treated neonatally with ACTH compared to those receiving saline ( Figure 3B-D) . There was no apparent effect of neonatal treatment on InsR abundance in the liver or biceps muscle ( Figure 3A&E ).
Relationships to birth weight and postnatal growth rates
When all data were combined irrespective of sex or treatment at each of the two ages, there was no relationship between birthweight (BW) and either AUCG or insulin sensitivity in the yearlings (P>0.05, both cases). In contrast, at 2 years of age, AUCG was inversely related to the birthweight ( Figure 4A , AUCG = 982 -13.0BW, n = 18, r = -0.487, P = 0.04) while, conversely, insulin sensitivity was positively correlated to birth weight of the foals ( Figure   4B , IS = -159 + 15.6BW, n = 17, r = 0.658, P = 0.04). There were no relationships between the fractional growth rate until the age at study (g/kg/day) and either AUCG or insulin sensitivity at 1 and 2 years of age (P>0.05, all cases). Nor was there any relationship between birthweight and AUCI at 1 and 2 years of age when the data from the two sexes were analysed separately (P>0.05, all cases).
DISCUSSION
The results demonstrate that sex, birth weight and neonatal glucocorticoid overexposure are all significant influences on the glucose-insulin dynamics of young adult horses. Insulin secretion in response to glucose was sex-linked at both ages studied as was insulin sensitivity in the yearlings. Birth weight was related to the action of insulin in the 2 year olds, irrespective of whether insulin effectiveness was measured as area under the AUCG in the glucose tolerance test or more directly as insulin sensitivity using the hyperinsulinaemiceuglycaemic clamp technique. In contrast, neonatal glucocorticoid overexposure appeared to have little effect on glucose tolerance, insulin secretion or insulin sensitivity of the horses at either age studied, although it did affect InsR abundance of specific skeletal muscles at 2 years in a manner independent of the sex of the animal. The current findings together with previous studies 21-23 suggest that sex of the animal and environmental factors during fetal and early neonatal life are likely to be important in determining postnatal metabolic and endocrine phenotype in horses as occurs in other species. 5, 6, 15, 16 Insulin secretion in response to glucose administration was greater in females than males at both 1 and 2 years, consistent with findings in newborn foals at 2 weeks of age. 23 Sex-linked differences in glucose-stimulated insulin release have also been reported in rats, guinea pigs and sheep postnatally, particularly when there is a suboptimal environment during their intrauterine development. 10, [35] [36] [37] [38] [39] [40] However, in these earlier studies, it was generally the males rather than the females that had a greater insulin response to exogenous glucose administration. In part, this was due to sex-linked changes in pancreatic β cell mass and/or alterations in the intracellular pathways of insulin secretion. [41] [42] [43] The mechanisms responsible for the differences in glucose-stimulated insulin secretion between the sexes in the horses in the current study are unknown.
Despite the difference in insulin secretion between the male and female horses, glucose dynamics and AUCG were unaffected by the sex of the ponies at both ages studied. This suggests that insulin sensitivity was greater in males than females. However, direct measurement of insulin sensitivity using hyperinsulinaemic-euglycaemic clamps showed that the females were the more insulin sensitive sex as yearlings with no difference between the sexes at 2 years of age. Sex-linked differences in adult insulin sensitivity have been observed previously in rats, guinea pigs, sheep and humans and are often related to differences in adiposity. 10, 11, 37, 39, 44, 45 Body condition score was maintained at moderate in all animals in the current study so changes in adiposity are unlikely to account for the sex-linked differences in insulin sensitivity seen in the yearlings. In a subset of the current 2 year old horses, there were also no apparent sex-linked differences in InsR abundance in the liver or skeletal muscles, the main sites of insulin action. Consequently, the paradoxical findings of no sexlinked difference in AUCG but increased insulin secretion and sensitivity in the female yearlings relative to the males indicates that any increased insulin-stimulated glucose uptake during the glucose tolerance test is probably balanced by an equal and opposite decrease in insulin independent glucose disposal in the females. Conversely, in the older animals, there were no differences in insulin sensitivity or glucose tolerance between the sexes, despite the smaller insulin response to glucose administration in the males, which suggests insulin dependent glucose uptake may be less while insulin independent glucose disposal may be greater in males than females during glucose administration at 2 years of age. There may, therefore, be sexual dimorphism in the tissue expression and relative abundance of the various glucose transporters (GLUTs) in equine tissues, which differ with age. Certainly, in other species, there are sex-linked differences in tissue abundance of both the insulin sensitive GLUT isoform, GLUT4, and the insulin-insensitive isoforms, GLUT1 and GLUT2 in the adult animal, particularly when it has experienced adverse conditions during intrauterine development. [46] [47] [48] [49] In the current study, the weight specific rates of glucose infusion during the clamp were within the range of values reported previously for adult horses of several different breeds including ponies. 33, [50] [51] [52] [53] [54] Collectively, these studies suggest that insulin sensitivity may vary between breeds with a trend towards greater insulin resistance in ponies than more athletic breeds of horse. They also indicate that insulin sensitivity may decline with age as GIR values tended to be lower in horses older than 12 years than in younger animals of the same breed. 17, 52, 54 Certainly, in the current study, insulin sensitivity decreased between 1 and 2 years of age in the females, although not the males. Since insulin sensitivity is affected by puberty in other species 55 , this may reflect, in part, the tendency for an earlier onset of puberty in fillies than colts. 56 The current finding that birth weight was inversely correlated to AUCG and positively related to insulin sensitivity in the 2 years old horses is consistent with previous studies of natural and experimentally induced variations in birth weight in other species. 5, 6, 15, 16 Adult insulin sensitivity is known to be less in smaller than larger littermates in pigs and guinea pigs. 10, 57, 58 Similarly, in Standardbred horses, insulin sensitivity is less in pre-weaning foals that were growth restricted than in those growth enhanced by embryo transfer into smaller and larger breeds of mares, respectively. 59 In addition, resistance to the effects of insulin is greater in adult rats of low birth weight, irrespective of whether intrauterine growth restriction was induced by uterine artery ligation, maternal glucocorticoid administration or restriction of dietary protein or calories intake. 13, 32, 35, 60 However, since insulin is an important regulator of fetal growth in species with relatively long gestational periods like the sheep and horse 16 , the relationship between adult insulin sensitivity and birth weight across the normal range may not be due to intrauterine programming but rather reflect an inherent, genetically determined insulin sensitivity tracking from fetal to early adult life. The absence of this relationship in the yearlings may again be the consequence of the changes in insulin sensitivity associated with puberty. 55, 56 In the current study, 
